newsfilter
← Latest News
Business Wire·

Cyteir Therapeutics to Participate in the 2022 Jefferies Healthcare Conference

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, announced that Markus Renschler, MD, President and Chief Executive Officer will participa